evonetix

About:

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

Website: http://evonetix.com/

Twitter/X: evonetix

Top Investors: Molten Ventures, Innovate UK, Foresite Capital, DCVC, Cambridge Consultants

Description:

evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniques we are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.

Total Funding Amount:

$68.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Little Chesterford, Essex, United Kingdom

Founded Date:

2015-01-01

Contact Email:

info(AT)evonetix.com

Founders:

Joseph Brennan, Matthew Hayes

Number of Employees:

101-250

Last Funding Date:

2023-02-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai